Announcement on Preliminary Earnings Estimate for 2025
Filed with SSE · · 3 pages · Chinese
Earlier from Sansure Biotech
- Announcement on Voluntary Disclosure of Clinical Trial Approval for New Indications of a Product of a Holding Subsidiary
- Announcement on Progress in Establishing a Fund through Co-investment with Professional Institutions and Related Party Transaction
- Announcement on Vesting Results for the 1st Vesting Period of the Initial Granted Part under the 2023 Phase II Restricted Stock Incentive Plan
- Announcement on Voluntary Disclosure in the Related Product Obtaining the EU CE Certification
- Indicative Announcement on Proposed Judicial Freezing and Enforcement of Some Shares Held by Shareholder with Over 5% Shares
Later from Sansure Biotech
- Announcement on Joint Investment with a Related Party in Beijing Zheyuan Technology Co., Ltd.
- Announcement on Joint Investment with a Related Party in Huasi Wuwei Technology (Shenzhen) Co., Ltd.
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
Follow Sansure Biotech into a list and get an email when it puts out news.
Follow Sansure Biotech